Coordinatore | INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR - IBMC
Organization address
address: RUA DO CAMPO ALEGRE 823 contact info |
Nazionalità Coordinatore | Portugal [PT] |
Totale costo | 557˙489 € |
EC contributo | 498˙555 € |
Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
Code Call | FP7-HEALTH-2013-INNOVATION-1 |
Funding Scheme | CSA-SA |
Anno di inizio | 2013 |
Periodo (anno-mese-giorno) | 2013-10-01 - 2016-09-30 |
# | ||||
---|---|---|---|---|
1 |
INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR - IBMC
Organization address
address: RUA DO CAMPO ALEGRE 823 contact info |
PT (PORTO) | coordinator | 138˙794.00 |
2 |
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Organization address
address: GESCHWISTER SCHOLL PLATZ 1 contact info |
DE (MUENCHEN) | participant | 87˙330.00 |
3 |
UNIVERSITEIT MAASTRICHT
Organization address
address: Minderbroedersberg 4-6 contact info |
NL (MAASTRICHT) | participant | 78˙761.00 |
4 | KOBENHAVNS UNIVERSITET | DK | participant | 78˙110.00 |
5 |
ISTITUTO SUPERIORE DI SANITA
Organization address
address: Viale Regina Elena 299 contact info |
IT (ROMA) | participant | 70˙620.00 |
6 |
THE UNIVERSITY OF SHEFFIELD
Organization address
address: FIRTH COURT WESTERN BANK contact info |
UK (SHEFFIELD) | participant | 44˙940.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'Research with animals is considered necessary to obtain certain vital knowledge for advancing health research and innovation, but the harm such research may cause animals is ethically problematic. The European legislation regulating animal experimentation is based on the need to balance the two important interests at stake: advancing research and protecting animal welfare. The public sensitivity of the issue is evidenced by the exceptional participation in the legislative process leading to a revised European legislation. Directive 2010/63/EU (presently under transposition into Member State legislation) will bring about substantial changes compared to the previous directive dating from 1986. One of the main objectives of revising this legislation is to create a greater harmonization of the governance of the use of animals in scientific (including medical) research for the European research area. The transposition is being accompanied by European Commission initiatives to promote a common interpretation of the legislation. However, major determinants of how research in Europe will be affected remain largely uncharted, in that little is published about how legal, ethical and scientific decisions about research will be made and how regulation will influence these decisions. A multidisciplinary team of academic researchers from different EU Member States will use literature reviews, questionnaires, interviews, and focus groups to provide a deeper understanding of how the regulation interacts with research and innovation through the new common legal framework for animal experimentation in the EU. ANIMPACT will address the effectiveness of the new Directive and the current law in relation to other established norms in ethics, law, and scientific research, with focus on its interaction with ethics review and project licensing processes. The project will further consider the impact of the Directive on academic and commercial competitiveness as well as on animal welfare.'
A phase I/IIa clinical trial in Duchenne muscular dystrophy using systemically delivered morpholino antisense oligomer to skip exon 53
Read More"Efficacy and safety of MRI-based thrombolysis in wake-up stroke: a randomised, double-blind, placebo-controlled trial"
Read MoreDefining the role of xeno-directed and autoimmune events in patients receiving animal-derived bioprosthetic heart valves
Read More